Sera Prognostics Inc Cl A (SERA)

$2.00 -0.01 (-0.50%)
Market Cap 79.29M
Revenue (ttm) 80,000.00
Net Income (ttm) -31.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39,912.50%
Debt to Equity Ratio 0.00
Volume 8,200
Avg Vol 31,620
Day's Range N/A - N/A
Shares Out 39.45M
Stochastic %K 13%
Beta 0.98
Analysts Strong Sell
Price Target $5.50

Company Profile

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy relate...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 990 0520
Fax: 801 990 6601
Address:
2749 East Parleys Way, Suite 200, Salt Lake City, United States
Jimbob3016
Jimbob3016 Aug. 25 at 2:16 PM
$CBAT just secured a 96 million $ order $SERA great news!!!
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 23 at 3:58 PM
$CLPT $MASS $OSUR $PDEX $SERA Discover 5 high-potential small-cap medical stocks ranked by revenue growth, commercial traction, financial strength, catalysts, valuation, and overall investment risk. https://biotechhealthx.com/biotech-news/top-10-small-cap-medical-stocks-to-buy-before-august-2026-ends/
0 · Reply
martyn78
martyn78 Aug. 15 at 3:36 AM
$SERA could see this getting some momentum
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 12 at 8:15 PM
$SERA Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.18 down -12.50% YoY • Reported revenue of $0.03M up 76.47% YoY
0 · Reply
Wes_g
Wes_g Jul. 22 at 2:39 AM
$SERA Core Value Drivers: Demonstrated healthcare cost savings from the PreTRM® test should support broader reimbursement coverage by commercial and government payers, reducing barriers to adoption and driving test volume growth. Strong clinical outcomes, including the ability to identify pregnancies at risk of preterm birth and enable earlier intervention, should increase physician confidence, support broader payer reimbursement, and accelerate adoption. Inclusion of the PreTRM® test in professional pregnancy care guidelines would establish it as part of the standard of care for appropriate patient populations, significantly expanding its addressable market and long-term adoption. Leveraging SERA's proprietary biomarker platform to develop additional maternal health diagnostics could increase the company's total addressable market and improve long-term growth prospects.
0 · Reply
BioTuesdays
BioTuesdays Jul. 10 at 7:39 PM
$SERA has announced publication of a new subgroup analysis from the PRIME trial demonstrating that its PreTRM Test-guided care in first-time pregnancies significantly improved neonatal outcomes, including a 22% reduction in neonatal intensive care unit (NICU) admissions. https://biotuesdays.com/2026/07/10/analysis-shows-22-cut-in-nicu-admissions-in-first-time-pregnancies-with-seras-pretrm/
0 · Reply
ctenidae
ctenidae Jul. 10 at 1:52 AM
$SERA https://www.sera.com/pregnancy-related-concerns/newsroom/prime-subgroup-analysis-demonstrates-22-reduction-in-nicu-admissions-in-first-time-pregnancies-using-pretrm-test-guided-care/ 22% reduction in NICU admissions. 2x decrease in NICU admissions for sPTB babies. Listen up, Illinois- this is good.
0 · Reply
ctenidae
ctenidae Jun. 1 at 12:23 PM
$SERA Illinois just passed new legislation mandating Sera' test: Page 390: Sec. 5-54. Coverage for proteomic blood tests. (a) The medical assistance program shall provide coverage and reimbursement for a prescribed proteomic blood test, with clinical trial proof of improved infant outcomes published in peer-reviewed journals, that identifies and quantifies the risk of preterm birth for an individual pregnancy https://ilga.gov/documents/legislation/104/SB/PDF/10400SB3365ham001.pdf
1 · Reply
SuperGreenToday
SuperGreenToday May. 29 at 1:02 AM
$SERA Share Price: $2.10 Contract Selected: Jan 15, 2027 $2.5 Calls Buy Zone: $0.38 – $0.47 Target Zone: $0.70 – $0.86 Potential Upside: 74% ROI Time to Expiration: 231 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
CH0WDER
CH0WDER May. 27 at 4:03 AM
$SERA touches 2.40 tmw 👏
0 · Reply
Latest News on SERA
1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.

Aug 25, 2026, 8:00 AM EDT - 16 days ago

1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.

Sera CFO Austin Aerts to transition out of role, Scott Gleason to succeed

2026-08-19T20:35:41.000Z - 21 days ago

Sera CFO Austin Aerts to transition out of role, Scott Gleason to succeed

NEOG

SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER

Aug 19, 2026, 4:30 PM EDT - 21 days ago

SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER

Sera Prognostics reports Q2 EPS (18c), consensus (16c)

2026-08-17T08:46:24.000Z - 24 days ago

Sera Prognostics reports Q2 EPS (18c), consensus (16c)

Sera Prognostics Earnings Call Transcript: Q2 2026

Aug 12, 2026, 5:00 PM EDT - 4 weeks ago

Sera Prognostics Earnings Call Transcript: Q2 2026

Sera Prognostics Earnings release: Q2 2026

Aug 12, 2026, 5:00 PM EDT - 4 weeks ago

Sera Prognostics Earnings release: Q2 2026

Sera Prognostics Quarterly report: Q2 2026

Aug 12, 2026, 5:00 PM EDT - 4 weeks ago

Sera Prognostics Quarterly report: Q2 2026

SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Aug 12, 2026, 4:05 PM EDT - 4 weeks ago

SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Sera Prognostics Slides: Corporate presentation

Aug 7, 2026, 7:00 AM EDT - 4 weeks ago

Sera Prognostics Slides: Corporate presentation

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026

Jul 29, 2026, 4:05 PM EDT - 6 weeks ago

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026

Sera Prognostics management to meet virtually with Craig-Hallum

2026-07-15T15:40:23.000Z - 1 month ago

Sera Prognostics management to meet virtually with Craig-Hallum

Sera Prognostics’ PreTRM Test shows efficacy guiding first-time pregnancy care

2026-07-09T20:15:51.000Z - 2 months ago

Sera Prognostics’ PreTRM Test shows efficacy guiding first-time pregnancy care

PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE

Jul 9, 2026, 4:05 PM EDT - 2 months ago

PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS

Jun 30, 2026, 4:05 PM EDT - 2 months ago

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS

Sera Prognostics part of ARPA-H award for birth safety test development

2026-06-24T20:16:01.000Z - 2 months ago

Sera Prognostics part of ARPA-H award for birth safety test development

ALGM

SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH

Jun 24, 2026, 4:05 PM EDT - 2 months ago

SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH

SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY

Jun 23, 2026, 4:05 PM EDT - 2 months ago

SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY

Sera Prognostics Transcript: AGM 2026

Jun 4, 2026, 11:00 AM EDT - 3 months ago

Sera Prognostics Transcript: AGM 2026

Craig-Hallum bullish on Sera Prognostics, initiates with a Buy

2026-06-04T13:41:51.000Z - 3 months ago

Craig-Hallum bullish on Sera Prognostics, initiates with a Buy

Sera Prognostics initiated with a Buy at Craig-Hallum

2026-06-04T11:20:37.000Z - 3 months ago

Sera Prognostics initiated with a Buy at Craig-Hallum

Sera Prognostics Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 9:20 AM EDT - 3 months ago

Sera Prognostics Transcript: Jefferies Global Healthcare Conference 2026

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION

Jun 1, 2026, 4:05 PM EDT - 3 months ago

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION

Sera Prognostics Proxy statement: Proxy filing

Jun 1, 2026, 8:00 AM EDT - 3 months ago

Sera Prognostics Proxy statement: Proxy filing

Sera Prognostics reports Q1 EPS (17c), consensus (17c)

2026-05-07T00:48:38.000Z - 4 months ago

Sera Prognostics reports Q1 EPS (17c), consensus (17c)

Sera Prognostics Earnings Call Transcript: Q1 2026

May 6, 2026, 5:00 PM EDT - 4 months ago

Sera Prognostics Earnings Call Transcript: Q1 2026

Sera Prognostics Earnings release: Q1 2026

May 6, 2026, 5:00 PM EDT - 4 months ago

Sera Prognostics Earnings release: Q1 2026

Sera Prognostics Quarterly report: Q1 2026

May 6, 2026, 5:00 PM EDT - 4 months ago

Sera Prognostics Quarterly report: Q1 2026

SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

May 6, 2026, 4:05 PM EDT - 4 months ago

SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

Sera Prognostics Slides: Corporate presentation

May 4, 2026, 7:00 AM EDT - 4 months ago

Sera Prognostics Slides: Corporate presentation

Sera Prognostics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Sera Prognostics Proxy statement: Proxy filing

Sera Prognostics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Sera Prognostics Proxy statement: Proxy filing

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026

Apr 22, 2026, 8:05 AM EDT - 4 months ago

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026

Sera Prognostics Slides: Corporate presentation

Apr 1, 2026, 3:30 AM EDT - 5 months ago

Sera Prognostics Slides: Corporate presentation

Sera Prognostics Earnings Call Transcript: Q4 2025

Mar 18, 2026, 5:00 PM EDT - 5 months ago

Sera Prognostics Earnings Call Transcript: Q4 2025

Sera Prognostics Annual report: Q4 2025

Mar 18, 2026, 5:00 PM EDT - 5 months ago

Sera Prognostics Annual report: Q4 2025

Sera Prognostics Earnings release: Q4 2025

Mar 18, 2026, 5:00 PM EDT - 5 months ago

Sera Prognostics Earnings release: Q4 2025

Sera Prognostics reports Q4 EPS (16c), consensus (19c)

2026-03-18T20:11:17.000Z - 5 months ago

Sera Prognostics reports Q4 EPS (16c), consensus (19c)

SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

Mar 18, 2026, 4:05 PM EDT - 5 months ago

SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

Sera Prognostics Slides: Corporate presentation

Mar 18, 2026, 7:00 AM EDT - 5 months ago

Sera Prognostics Slides: Corporate presentation

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026

Mar 4, 2026, 8:05 AM EST - 6 months ago

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026

Sera Prognostics Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 1:10 PM EST - 6 months ago

Sera Prognostics Transcript: TD Cowen 46th Annual Health Care Conference

SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE

Feb 17, 2026, 8:05 AM EST - 6 months ago

SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE

Sera Prognostics Slides: Corporate presentation

Feb 10, 2026, 7:00 AM EST - 7 months ago

Sera Prognostics Slides: Corporate presentation

Sera Prognostics initiated with a Buy at Jefferies

2025-12-14T17:35:07.000Z - 8 months ago

Sera Prognostics initiated with a Buy at Jefferies

Sera Prognostics announces publication acceptance for PRIME study

2025-11-24T13:10:59.000Z - 9 months ago

Sera Prognostics announces publication acceptance for PRIME study

Sera Announces Publication Acceptance for PRIME Study

Nov 24, 2025, 8:00 AM EST - 9 months ago

Sera Announces Publication Acceptance for PRIME Study

Sera Prognostics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 5:00 PM EST - 10 months ago

Sera Prognostics Earnings Call Transcript: Q3 2025

Sera Prognostics Quarterly report: Q3 2025

Nov 13, 2025, 5:00 PM EST - 10 months ago

Sera Prognostics Quarterly report: Q3 2025

Sera Prognostics Earnings release: Q3 2025

Nov 13, 2025, 5:00 PM EST - 10 months ago

Sera Prognostics Earnings release: Q3 2025

SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

Nov 13, 2025, 4:05 PM EST - 10 months ago

SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025

Oct 30, 2025, 4:05 PM EDT - 10 months ago

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025

Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer

Oct 1, 2025, 8:05 AM EDT - 11 months ago

Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer

Sera Prognostics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 5, 2025, 7:00 AM EDT - 1 year ago

Sera Prognostics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sera Prognostics Slides: H.C. Wainwright 27th Annual Global Investment Conference

Sep 5, 2025, 7:00 AM EDT - 1 year ago

Sera Prognostics Slides: H.C. Wainwright 27th Annual Global Investment Conference

SERA PROGNOSTICS TO PRESENT AT H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE

Aug 28, 2025, 8:05 AM EDT - 1 year ago

SERA PROGNOSTICS TO PRESENT AT H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE

Sera Prognostics Earnings Call Transcript: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings Call Transcript: Q2 2025

Sera Prognostics Quarterly report: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Quarterly report: Q2 2025

Sera Prognostics Earnings release: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings release: Q2 2025

SERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

Aug 6, 2025, 4:05 PM EDT - 1 year ago

SERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

Sera Prognostics Slides: Corporate Presentation

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Sera Prognostics Slides: Corporate Presentation

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025

Jul 29, 2025, 4:05 PM EDT - 1 year ago

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025

SERA PROGNOSTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

May 29, 2025, 8:30 AM EDT - 1 year ago

SERA PROGNOSTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Sera Prognostics Transcript: RBC Capital Markets Global Healthcare Conference 2025

May 21, 2025, 9:30 AM EDT - 1 year ago

Sera Prognostics Transcript: RBC Capital Markets Global Healthcare Conference 2025

SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE

May 14, 2025, 4:05 PM EDT - 1 year ago

SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE

Sera Prognostics names Lee Anderson as Chief Commercial Officer

2025-05-08T20:48:41.000Z - 1 year ago

Sera Prognostics names Lee Anderson as Chief Commercial Officer

SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER

May 8, 2025, 4:40 PM EDT - 1 year ago

SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER

Sera Prognostics Earnings Call Transcript: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings Call Transcript: Q1 2025

Sera Prognostics Quarterly report: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Quarterly report: Q1 2025

Sera Prognostics Earnings release: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings release: Q1 2025

SERA PROGNOSTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

May 7, 2025, 4:05 PM EDT - 1 year ago

SERA PROGNOSTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2025 Financial Results on May 7, 2025

Apr 24, 2025, 8:30 AM EDT - 1 year ago

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2025 Financial Results on May 7, 2025

Sera Prognostics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Sera Prognostics Proxy statement: Proxy Filing

Sera Prognostics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Sera Prognostics Proxy statement: Proxy Filing

Sera Prognostics Earnings Call Transcript: Q4 2024

Mar 19, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings Call Transcript: Q4 2024

Sera Prognostics Annual report: Q4 2024

Mar 19, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Annual report: Q4 2024

Sera Prognostics Earnings release: Q4 2024

Mar 19, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings release: Q4 2024

Sera Prognostics appoints Jeff Elliott to Board, two members stepping down

2025-03-19T20:15:55.000Z - 1 year ago

Sera Prognostics appoints Jeff Elliott to Board, two members stepping down

Sera Prognostics reports Q4 EPS (25c) vs. (25c) last year

2025-03-19T20:11:42.000Z - 1 year ago

Sera Prognostics reports Q4 EPS (25c) vs. (25c) last year

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

Mar 19, 2025, 4:10 PM EDT - 1 year ago

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS

Mar 19, 2025, 4:05 PM EDT - 1 year ago

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS

Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2024 Financial Results on March 19, 2025

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2024 Financial Results on March 19, 2025

Sera Prognostics Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 5, 2025, 9:50 AM EST - 1 year ago

Sera Prognostics Transcript: TD Cowen 45th Annual Healthcare Conference

Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference

Feb 21, 2025, 8:30 AM EST - 1 year ago

Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference

Sera Prognostics announces pricing of $50M public offering

2025-02-11T11:15:54.000Z - 1 year ago

Sera Prognostics announces pricing of $50M public offering

Sera Prognostics Announces Pricing of $50 Million Public Offering

Feb 10, 2025, 10:41 PM EST - 1 year ago

Sera Prognostics Announces Pricing of $50 Million Public Offering

Sera Prognostics announces Class A common stock offering

2025-02-10T21:11:44.000Z - 1 year ago

Sera Prognostics announces Class A common stock offering

Sera Prognostics Announces Proposed Public Offering

Feb 10, 2025, 4:01 PM EST - 1 year ago

Sera Prognostics Announces Proposed Public Offering

Sera Prognostics Transcript: R&D Day 2025

Jan 31, 2025, 5:00 PM EST - 1 year ago

Sera Prognostics Transcript: R&D Day 2025

Sera Prognostics Slides: FY 2025

Jan 31, 2025, 5:00 PM EST - 1 year ago

Sera Prognostics Slides: FY 2025

Sera Prognostics to Host Virtual R&D Day on January 31

Jan 27, 2025, 5:02 PM EST - 1 year ago

Sera Prognostics to Host Virtual R&D Day on January 31

Sera Prognostics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 16, 2025, 12:45 PM EST - 1 year ago

Sera Prognostics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Sera Prognostics Slides: FY 2025

Jan 16, 2025, 12:45 PM EST - 1 year ago

Sera Prognostics Slides: FY 2025

Sera Prognostics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 8:30 AM EST - 1 year ago

Sera Prognostics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Sera Prognostics Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 5, 2024, 2:30 PM EST - 1 year ago

Sera Prognostics Transcript: Piper Sandler 36th Annual Healthcare Conference

Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting

Dec 4, 2024, 4:01 PM EST - 1 year ago

Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting

Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference

Dec 2, 2024, 8:30 AM EST - 1 year ago

Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference

Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Nov 15, 2024, 8:30 AM EST - 1 year ago

Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Sera Prognostics Earnings Call Transcript: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Sera Prognostics Earnings Call Transcript: Q3 2024

Sera Prognostics Quarterly report: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Sera Prognostics Quarterly report: Q3 2024

Sera Prognostics Earnings release: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Sera Prognostics Earnings release: Q3 2024

SERA PROGNOSTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

Nov 6, 2024, 4:05 PM EST - 1 year ago

SERA PROGNOSTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024

Oct 28, 2024, 8:30 AM EDT - 1 year ago

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024

Sera Prognostics Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 11, 2024, 10:00 AM EDT - 1 year ago

Sera Prognostics Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 4:53 PM EDT - 2 years ago

Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Sera Prognostics Transcript: UBS Genomic Medicine Conference

Aug 14, 2024, 11:00 AM EDT - 2 years ago

Sera Prognostics Transcript: UBS Genomic Medicine Conference

Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024

Sera Prognostics files $100M mixed securities shelf

2024-08-07T21:19:52.000Z - 2 years ago

Sera Prognostics files $100M mixed securities shelf

Sera Prognostics Earnings Call Transcript: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Earnings Call Transcript: Q2 2024

Sera Prognostics Quarterly report: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Quarterly report: Q2 2024

Sera Prognostics Earnings release: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Earnings release: Q2 2024

SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

Aug 7, 2024, 4:05 PM EDT - 2 years ago

SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

Sera Prognostics Registration statement: Registration Filing

Aug 7, 2024, 8:00 AM EDT - 2 years ago

Sera Prognostics Registration statement: Registration Filing

Sera Prognostics Inc trading resumes

2024-08-05T13:35:30.000Z - 2 years ago

Sera Prognostics Inc trading resumes

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024

Jul 25, 2024, 8:30 AM EDT - 2 years ago

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024

Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial

Jul 9, 2024, 8:30 AM EDT - 2 years ago

Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial

SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION

Jul 1, 2024, 8:30 AM EDT - 2 years ago

SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION

SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES

May 28, 2024, 8:30 AM EDT - 2 years ago

SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES

Sera Prognostics Earnings Call Transcript: Q1 2024

May 8, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Earnings Call Transcript: Q1 2024

Sera Prognostics Quarterly report: Q1 2024

May 8, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Quarterly report: Q1 2024

Sera Prognostics Earnings release: Q1 2024

May 8, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Earnings release: Q1 2024

SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

May 8, 2024, 4:05 PM EDT - 2 years ago

SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024

Apr 29, 2024, 2:15 PM EDT - 2 years ago

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024

Sera Prognostics Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Sera Prognostics Proxy statement: Proxy Filing

Sera Prognostics Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Sera Prognostics Proxy statement: Proxy Filing

Sera Prognostics Earnings Call Transcript: Q4 2023

Mar 20, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Earnings Call Transcript: Q4 2023

Sera Prognostics Annual report: Q4 2023

Mar 20, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Annual report: Q4 2023

Sera Prognostics Earnings release: Q4 2023

Mar 20, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Earnings release: Q4 2023

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS

Mar 20, 2024, 4:05 PM EDT - 2 years ago

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS

Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2023 Financial Results on March 20, 2024

Mar 4, 2024, 8:30 AM EST - 2 years ago

Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2023 Financial Results on March 20, 2024

Jimbob3016
Jimbob3016 Aug. 25 at 2:16 PM
$CBAT just secured a 96 million $ order $SERA great news!!!
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 23 at 3:58 PM
$CLPT $MASS $OSUR $PDEX $SERA Discover 5 high-potential small-cap medical stocks ranked by revenue growth, commercial traction, financial strength, catalysts, valuation, and overall investment risk. https://biotechhealthx.com/biotech-news/top-10-small-cap-medical-stocks-to-buy-before-august-2026-ends/
0 · Reply
martyn78
martyn78 Aug. 15 at 3:36 AM
$SERA could see this getting some momentum
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 12 at 8:15 PM
$SERA Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.18 down -12.50% YoY • Reported revenue of $0.03M up 76.47% YoY
0 · Reply
Wes_g
Wes_g Jul. 22 at 2:39 AM
$SERA Core Value Drivers: Demonstrated healthcare cost savings from the PreTRM® test should support broader reimbursement coverage by commercial and government payers, reducing barriers to adoption and driving test volume growth. Strong clinical outcomes, including the ability to identify pregnancies at risk of preterm birth and enable earlier intervention, should increase physician confidence, support broader payer reimbursement, and accelerate adoption. Inclusion of the PreTRM® test in professional pregnancy care guidelines would establish it as part of the standard of care for appropriate patient populations, significantly expanding its addressable market and long-term adoption. Leveraging SERA's proprietary biomarker platform to develop additional maternal health diagnostics could increase the company's total addressable market and improve long-term growth prospects.
0 · Reply
BioTuesdays
BioTuesdays Jul. 10 at 7:39 PM
$SERA has announced publication of a new subgroup analysis from the PRIME trial demonstrating that its PreTRM Test-guided care in first-time pregnancies significantly improved neonatal outcomes, including a 22% reduction in neonatal intensive care unit (NICU) admissions. https://biotuesdays.com/2026/07/10/analysis-shows-22-cut-in-nicu-admissions-in-first-time-pregnancies-with-seras-pretrm/
0 · Reply
ctenidae
ctenidae Jul. 10 at 1:52 AM
$SERA https://www.sera.com/pregnancy-related-concerns/newsroom/prime-subgroup-analysis-demonstrates-22-reduction-in-nicu-admissions-in-first-time-pregnancies-using-pretrm-test-guided-care/ 22% reduction in NICU admissions. 2x decrease in NICU admissions for sPTB babies. Listen up, Illinois- this is good.
0 · Reply
ctenidae
ctenidae Jun. 1 at 12:23 PM
$SERA Illinois just passed new legislation mandating Sera' test: Page 390: Sec. 5-54. Coverage for proteomic blood tests. (a) The medical assistance program shall provide coverage and reimbursement for a prescribed proteomic blood test, with clinical trial proof of improved infant outcomes published in peer-reviewed journals, that identifies and quantifies the risk of preterm birth for an individual pregnancy https://ilga.gov/documents/legislation/104/SB/PDF/10400SB3365ham001.pdf
1 · Reply
SuperGreenToday
SuperGreenToday May. 29 at 1:02 AM
$SERA Share Price: $2.10 Contract Selected: Jan 15, 2027 $2.5 Calls Buy Zone: $0.38 – $0.47 Target Zone: $0.70 – $0.86 Potential Upside: 74% ROI Time to Expiration: 231 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
CH0WDER
CH0WDER May. 27 at 4:03 AM
$SERA touches 2.40 tmw 👏
0 · Reply
makesomemoneybro123
makesomemoneybro123 May. 26 at 4:13 PM
$CETX $CXAI $SERA $MOB $KTOS You were right! -9% today! What a momentum
0 · Reply
CH0WDER
CH0WDER May. 26 at 4:07 PM
$SERA POWA
0 · Reply
CH0WDER
CH0WDER May. 26 at 3:02 PM
$SERA PUSH
0 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 23 at 1:12 AM
$SERA rocky hail mary
0 · Reply
topstockalerts
topstockalerts May. 23 at 1:08 AM
$SERA today’s quiet outperformer right here.
0 · Reply
CH0WDER
CH0WDER May. 22 at 7:05 PM
$SERA push!!!!
0 · Reply
MilsLearning
MilsLearning May. 22 at 9:40 AM
$SERA
0 · Reply
nevernevernevergoingdown
nevernevernevergoingdown May. 22 at 9:00 AM
$SERA potential news here
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 8:15 PM
$SERA Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.17 up 15.00% YoY • Reported revenue of $0.01M down -63.16% YoY • Sera Prognostics anticipates meaningful cost savings of approximately $9.6M in 2027, with decreased cash expenses of approximately 35% in R&D and 25% in G&A, expecting existing cash to fund operations through 2029.
0 · Reply